Journal of Applied Food Technology • pISSN 2355-9152 • eISSN 2614-7076 • Member of CrossRef®

Open Journal Systems

Malonaldehyde Level of Administration Ethanol Extract of Purple Sweet Potato Var. Ayamurasaki in Doca-Salt Hypertensive Rats

Irma Sarita Rahmawati, Soetjipto Soetjipto, Annis Catur Adi, Aulanni’am Aulanni’am


There is an increasing amount of evidence that oxidative stress related to hypertension can damage the function of diverse structures such as aorta. It is a well-established fact that chlorogenic acid and anthocyanine found in purple sweet potato generates bioactive compound with antihypertensive and antioxidant activities. The present study sought to investigate antioxidant activity of extract ethanol of purple sweet potato (EP) in deoxycorticosterone acetate (DOCA–salt)–induced hypertensive rats (Rattus norvegicus). The rats were orally administrated a 95% ethanol extract of purple sweet potato (var. Ayamurasaki) (EP) in a daily dose of 200 and 400 mg/kg body weight for 4 weeks. Aorta total malondialdehyde (MDA) and histopathology of aorta abdominal were examined. Aorta injury was observed in DOCA-salt hypertensive group rats compared to normotensive group rats, as aorta MDA significantly increased  (P <0.05). In contrast, treatment of DOCA-salt hypertensive rats with different dose of EP significantly reduced the total aorta MDA, as well as repair kidney damage, suppressed smooth muscle cell proliferation and lessen aorta wall thickening compared to controls.   This is the first report that demonstrated blood pressure lowering and antioxidative effects of an ethanol extract of purple sweet potato, containing chlorogenic acid, in a DOCA–salt model of hypertension.


Extract ethanol of purple sweet potato (EP), DOCA–salt, Chlorogenic acid, Antioxidant, malondialdehyde (MDA)

Full Text:



Atlas, S. A. 2007. The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition. J. Manag. Care. Pharm., 13(8)(Suppl S-b): S9-S20.

Aulanni’am., A. Roosdiana, and N.L. Rahmah. 2012. The potency of sargassum duplicatum bory extract on inflammatory bowel disease theraphy in rattus norvegicus. J. Life Sci., , 6 : 144-154.

Badyal, D.K., H. Lata and A. P. Dadhich. 2003. Animal models of hypertension and effect of drugs. Indian J Pharmacol., 35: 349-362.

del Mar Contreras, M., R. Carro´n, M. J. Montero, M. Ramos and I. Recio. 2009. Novel extract ethanol purple sweet potatoes-derived peptides with antihypertensive activity. J. Intern. Dairy ,19: 566–573.

Dornas, W. C And M. E. Silva. 2011. Animal models for the study of arterial hypertension. J. Biosci., , 36 : 1-13.

Ferrario, C. M. 2010. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin–angiotensin–aldosterone system: Antihypertensive effects and benefits beyond BP control. J. Life Sci., , 86: 289–299.

Harrison, DG., Gongora MC ., Guzik TJ., & Widder J ., 2007. Oxidative stress and hypertension. J. Am.Society of Hyperten.,1(1) : 30–44

Hong H.J., Loh S.H., and Yen M.H., 2000, Suppresion of The Development of Hypertension by The inhibitor of Indiucible Nitric Oxide Synthase, British Journal of Pharmacology, Vol: 131: 631-637.

Jiménez, R., R. L.Sepúlveda., M. Kadmiri, M. Romero, R. Vera., M. Sánchez, F. Vargas, F. O'Valle, A. Zarzuelo, M. Dueñas, C. S. Buelga and J. Duarte. 2007. Polyphenols restore endothelial function in DOCA-salt hypertension: Role of endothelin-1 and NADPH oxidase. Free Rad Bio & Med., 43:462–473.

Khorshid, O., E. Abdel-Ghaffar., A. Mishriki., A. Galal1 and A. Hareedy. 2012. Possible cardiovascular protective effect of some Ppar activators in experimentally-induced hypertensive model in rats. Asian J. of Pharmaceutic. and Clin. Res.,.5(3): 67-72.

Phelan, M. A., Aherne, R. J. FitzGerald and N.M. O’Brien. 2009. Extract ethanol purple sweet potatoes-derived bioactive peptides:Biological effects, industrial uses, safety aspects and regulatory status. Int. Dairy. J., ,19: 643–654.

Prahalathan, P., S. Kumar and B. Raja. 2012. Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study. Asian Pacific J. Tropical Biomed., 443-448.

Ramos-Nino, M. E., and S. R. Blumen. 2009. Benefits of ACE Inhibitors in Diabetes. Clin. Med.Therapeutics, 1: 1041–1051.

Rubattu S., Pagliaro B., Pierelli G., Santolamazza C., Di Castro S , Mennuni S and Volpe M., 2015. Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress. Int. J. Mol. Sci., 16: 823-839

Rumbaoa, R.G.O., D.F. Cornago, and I.M. Geronimo. 2009. Phenolic content and antioxidant capacity of Philippine sweet potato (Ipomoea batatas) varieties. Food Chem. 2009. 113:1133-1138.

Sah, B.N.P. , T. Vasiljevic, S. McKechnie, O.N. Donkor. 2014. Effect of probiotics on antioxidant and antimutagenic activities of crude peptide extract from yogurt. Food Chem., 156 264–270.

Sharma., P. K., N. S. Vyawahare and A. Ladhha. 2010. Preclinical screnig models for hypertesion in rodents: a review. Pharmacologyonline, ,3: 458-472.

Sun Y., Carretero O.A., Xu J., Rhaleb N.E., Yang J.J., Pagano P.J., and Yang X.P., 2009, Deletion of iNOS Provides Cardioprotection in Mice with 2-Kidney, 1-Clip Hypertension, Journal of Hypertenion, Vol: 53(1): 49-56.

Sun Y., Carretero O.A., Xu J., Rhaleb N.E., Wang F., Lin C., Yang J.J., Pagano P.J., and Yang X.P., 2005, Lack of Inducible NO Synthase Reduces Oxidative Stress and Enhances Cardiac Response to Isoproterenol in Mice with Deoxycorticosterone Acetate-Salt Hypertension, Journal of Hypertension, Vol: 46(6): 1355-1361.

Timón,M.L, Parra,V. Otte, J. Broncano,J.M. Petrón, M.J. 2014. Identification of radical scavenging peptides (<3 kDa) from Burgos-type cheese. LWT - Food Sci. Technol., , 57: 359-365 .

Vaziri ND. 2008. Causal Link Between Oxidative Stress, Inflammation, and Hypertension. Iranian J. Of Kidney Dis.,;2:1-10

Wang, X.J., Xi-qun Zheng, N. Kopparapu, Wan-suo Cong,Yong-ping Deng, Xiu-jiao Sun, Xiao-lan Liu Wang X-j. 2014. Purification and evaluation of a novel antioxidant peptide from corn protein hydrolysate. Process Biochem., ,

Yashimoto, M., S. Okuna, M. Yoshinaga, O. Yamakawa, M. Yamaguchi, and J. Yamada. 1999. Antimutagenicity of sweet potato (Ipomoae batatas) root. Biosci. Biotech. Biochem.,. 63:541-543



  • There are currently no refbacks.